Creative Disruption Forum
Get ready to shake up the future of AI, advanced therapies, and biologics at #CreativeDisruption – it’s going to be truly thought-provoking!
What are the latest trends, developments and strategies in AI for emerging biotech, Advanced Therapies and Biologics. This is what we are going to discuss in our Friday 12 December Creative Disruption Forum at the ARC West London in Hammersmith. Here are some initial thoughts on what could be discussed.
Artificial Intelligence (AI) is transforming the landscape of biotechnology, particularly in the sectors of Biologics and Advanced Therapies in the UK. The integration of AI technologies into research and development processes is enabling quicker drug discovery, enhanced predictive modeling, and improved clinical trial designs. One notable trend is the use of machine learning algorithms to analyze vast datasets, allowing for the identification of new biomarkers and therapeutic targets. Researchers can leverage AI to predict how biological systems will respond to certain treatments, thus optimizing the design of biologics and advanced therapies tailored to individual patient needs. Strategically, UK biotech firms are increasingly forming partnerships with tech companies to harness AI capabilities. These collaborations facilitate access to advanced data analytics, enhancing the efficiency of research pipelines. The government also supports this trend through funding initiatives aimed at fostering AI innovations in biotech. Moreover, AI applications in drug repurposing are gaining traction, allowing companies to effectively reposition existing drugs for new indications, thus accelerating the development timeline and reducing costs. As the UK continues to embrace AI, it is well-positioned to maintain its leadership in the Biologics and Advanced Therapies sectors, driving forward both scientific advancements and commercial success.
Keynotes interviews to be announced soon.
The structure of our interview lead discussion Creative Disruption Forum is as follows:
10-10.30 am arrival with coffee & teas, biscuits & fruit
10.30-10.45 am – introductions to our Supporting Sponsors
10.45 – 11.15 am – Keynote interview on how emerging biotechs should be utilising existing AI
Amjad Khan, Pfizer and Changely.ai – evangelising on how emerging biotech should leveraging AI in today’s world
Shabnam Raja, Cognizant – on the digital transformation of biotech
11.15 -11.45 am – keynote interviewees on the latest trends and strategies on Biologics companies
Andrew Buchanan, Khanda Tx
11.45am -12 pm – coffee & tea break, snacks
12-12.30 pm – keynote interviews on the latest trends and strategies for Advanced Therapeutics Companies
12.30-1 pm – keynote interviews from the “boots on the ground companies” – what are they seeing?
1-2 pm – light lunch with coffee + refreshments (provided)
at 1.30 pm Lab Tour available
2-3 pm – 6-8 workshops with a Group Leader on each – participants get to choose two topic areas from a choice of 6 topics that they would like to discuss in two 30 minute Workshops that are related to the morning discussions – This a great way for everyone to get to know each other.
3-3.45 pm- The workshop Group Leaders overview their discussions – designated Group Leaders who are Subject Experts get to summarise what was discussed in the Workshops
3.45.-4.00 pm – Tony Sedgwick summaries the day with the group
4.00 pm – 5.00pm – Networking and Christmas Drinks at ARC Hammersmith – 4.30 pm Lab Tour available for those that want it.
5pm onwards – Unofficial Christmas networking and drinks at a pub nearby – The Blue Boat
More Events
Wreath making Workshop
Festive Party
